Batavia Biosciences Receives $13.2M Grant to Accelerate Market Access of Low-cost Inactivated Polio Vaccine

Leiden, The Netherlands, Feb. 25 (Korea Bizwire) – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade inactivated polio vaccine (sIPV), using its newly developed low-cost polio vaccine manufacturing process (marketed as HIP-IPVTM) based on the NevoLine™ manufacturing technology developed by Univercells. In [...]